New hope for kids with tough cancers: drug shows promise in early trial

NCT ID NCT04447755

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times

Summary

This study tested the drug lenvatinib in 127 children, adolescents, and young adults whose solid tumors had come back or stopped responding to treatment. The goal was to see if the drug could shrink tumors and to check for side effects. Participants were grouped by tumor type, including Ewing sarcoma, rhabdomyosarcoma, and brain tumors. The study found that lenvatinib may help control some tumors, but it is not a cure and ongoing management is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • A.O.Universitaria Meyer-Oncology & Haematology Unit ( Site 0400)

    Florence, Tuscany, 50139, Italy

  • Asan Medical Center ( Site 0876)

    Songpagu, Seoul, 05505, South Korea

  • Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi OktatoKorhaz ( Site 0678)

    Miskolc, Borsod-Abauj Zemplen county, 3526, Hungary

  • Cancercare Rondebosch Oncology ( Site 0575)

    Cape Town, Western Cape, 7700, South Africa

  • Centre Leon-Berard ( Site 0326)

    Lyon, Auvergne, 69008, France

  • Chaim Sheba Medical Center ( Site 0500)

    Ramat Gan, 5265601, Israel

  • Children's Hospital of Colorado ( Site 0110)

    Aurora, Colorado, 80045, United States

  • Cleveland Clinic ( Site 0119)

    Cleveland, Ohio, 44195, United States

  • Clinica Anglo Americana ( Site 0203)

    San Isidro, Lima region, 15073, Peru

  • Clinical Research Center of specialized types medical care-Oncology ( Site 0553)

    Saint Petersburg, Sankt-Peterburg, 197758, Russia

  • Debreceni Egyetem Klinikai Kozpont ( Site 0677)

    Debrecen, 4032, Hungary

  • Dmitry Rogachev National Research Center ( Site 0550)

    Moscow, Moscow, 117198, Russia

  • Dokuz Eylul Universitesi Arastirma Uygulama Hastanesi ( Site 0602)

    Izmir, 35330, Turkey (Türkiye)

  • Ege Universitesi Tip Fakultesi ( Site 0601)

    Izmir, 35040, Turkey (Türkiye)

  • Fakultni Nemocnice Brno Bohunice ( Site 0651)

    Brno, Brno-mesto, 613 00, Czechia

  • Fakultni nemocnice v Motole ( Site 0650)

    Prague, 150 06, Czechia

  • Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0401)

    Milan, 20133, Italy

  • Gustave Roussy ( Site 0327)

    Villejuif, Val-de-Marne, 94800, France

  • Hacettepe Universitesi Tip Fakultesi ( Site 0603)

    Ankara, 06100, Turkey (Türkiye)

  • Hopital La Timone ( Site 0328)

    Marseille, Bouches-du-Rhone, 13005, France

  • Hospital Nino Jesus ( Site 0477)

    Madrid, 28009, Spain

  • Hospital Universitario Austral ( Site 0126)

    Pilar, Buenos Aires, B1629ODT, Argentina

  • Hospital Universitario Sant Joan de Deu ( Site 0476)

    Esplugues de Llobregat, Barcelona, 08950, Spain

  • Hospital de Niños Ricardo Gutiérrez ( Site 0125)

    Buenos Aires, Buenos Aires F.D., C1425EFD, Argentina

  • IRCCS Ospedale Pediatrico Bambino Gesu ( Site 0410)

    Rome, Roma, 00165, Italy

  • Institut Curie ( Site 0325)

    Paris, 75005, France

  • Institute for Oncology and Radiology of Serbia ( Site 0780)

    Belgrade, Beograd, 11000, Serbia

  • Istanbul Universitesi Onkoloji Enstitusu ( Site 0600)

    Istanbul, 34093, Turkey (Türkiye)

  • Istituto Giannina Gaslini ( Site 0411)

    Genova, 16147, Italy

  • Klinicki bolnicki centar Rijeka ( Site 0726)

    Rijeka, Primorje-Gorski Kotar County, 51000, Croatia

  • Klinika za djecje bolesti Zagreb ( Site 0725)

    Zagreb, Zagreb County, 10000, Croatia

  • Mary Crowley Cancer Research Center ( Site 0107)

    Dallas, Texas, 75230, United States

  • Medi-K Cayala ( Site 0177)

    Guatemala City, 01016, Guatemala

  • Monroe Carell Jr. Children's Hospital at Vanderbilt ( Site 0102)

    Nashville, Tennessee, 37232, United States

  • Ospedale Infantile Regina Margherita ( Site 0412)

    Torino, 10126, Italy

  • Perth Children s Hospital ( Site 0803)

    Nedlands, Western Australia, 6009, Australia

  • Queensland Children s Hospital ( Site 0804)

    Brisbane, Queensland, 4101, Australia

  • Royal Childrens Hospital Melbourne ( Site 0802)

    Parkville, Victoria, 3052, Australia

  • Semmelweis University ( Site 0675)

    Budapest, 1094, Hungary

  • Seoul National University Hospital ( Site 0875)

    Seoul, 03080, South Korea

  • Skanes Universitetssjukhus Lund. ( Site 0525)

    Lund, Skåne County, 221 85, Sweden

  • St.Petersburg State Medical Univ. n.a. acad. I.P.Pavlov ( Site 0554)

    Saint Petersburg, Sankt-Peterburg, 197022, Russia

  • Starship Childrens Hospital ( Site 0826)

    Auckland, 1023, New Zealand

  • Sydney Children's Hospital ( Site 0801)

    Randwick, New South Wales, 2031, Australia

  • Tygerberg Hospital ( Site 0578)

    Parow, Western Cape, 7505, South Africa

  • UZ Gent ( Site 0250)

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • Unidad Nacional de Oncologia Pediatrica ( Site 0176)

    Guatemala City, 01011, Guatemala

  • Univerzitetska decja klinika ( Site 0782)

    Belgrade, Beograd, 11000, Serbia

  • Wits Clinical Research ( Site 0579)

    Soweto, Gauteng, 2013, South Africa

Conditions

Explore the condition pages connected to this study.